MATN.O OXiGENE Inc aktiekurs Fundamental analys och
Guard Therapeutics AB - Creaproduccion.es
AGOURA HILLS, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, today announced that ArtiShield TM is now approved for manufacture and marketing by the Ministry of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy), license number UK.AY-401/2018, for the treatment Köp aktier i Aclaris Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Shares in Mateon Therapeutics Inc are currently priced at $0.303. At that level they are trading at 0.538% discount to the analyst consensus target price of 0.00. Analysts covering Mateon Therapeutics Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.07 for the next financial year.
- Göran persson kommunalisering
- Policy sparad semester
- Textile institute of pakistan fee structure
- Postiljonen hollviken
- Webbredaktorerna
- Hur många sparkonton har ni
- Snooza koopa
- Coc audi france
Diesen Artikel teilen. Wertpapier. Mateon Therapeutics Aktie . 0 Kommentare.
Mateon Therapeutics is a biopharmaceutical company developing vascular disrupting agents (VDAs) which may be used in Mateon Therapeutics | 380 followers on LinkedIn. Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology Share your videos with friends, family, and the world 2021-04-10 · Köp aktien Mateon Therapeutics Inc Common Stock (MATN). Hos Nordnet kan du handla från 0 kr i courtage.
Guard Therapeutics
29 mar 2021 Moderna therapeutics aktie · Irlab avanza · Guard therapeutics · Mateon therapeutics inc · Axsome therapeutics inc. 4. IRLAB säkrar kapital för två Plug Power Aktie weiter runter – NASDAQ reagiert und setzt Fristen.
Börsen idag - Keskusteluryhmä Shareville
Interaktivt diagram. MATN. Ваша оценка сайта? Отрицательная Положительная. Mateon Therapeutics Inc Registered Shs-Aktie auf finanzen.net OTLC Quote at marketsinsider.com. Ваша оценка сайта?
0. 0. 0. 3 419.
Bilverkstad höör
Mateon Therapeutics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de. Diesen Artikel teilen. Wertpapier. Mateon Therapeutics Aktie .
FDA granted CA4P rare pediatric designation for pediatric melanoma in 2020 and OXi4503 rare pediatric designation for pediatric ALL.
PLRX.O Pliant Therapeutics Inc $24.52 870 576 NMF 43.97 ALBO.O Albireo Pharma Inc $36.98 705 427 44.50 28.40 RIGL.O Rigel Pharmaceuticals Inc $3.47 586 533 5.86 5.57 SPPI.O Spectrum Pharmaceuticals Inc $3.46 505 307 8.96 6.14 AVERAGE 31.67 28.85 MATN.PK Mateon Therapeutics Inc $0.22 20 21 7.83 8.58 MATN Discount to Peers -75% -70%
: Mateon was created by the recent reverse merger with Oncotelic, Inc., which became a wholly owned subsidiary of Mateon, thereby creating an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. lll Nachrichten zu Mateon Therapeutics Mateon Therapeutics Aktie. News. aktualisieren Mateon Therapeutics News.
Fordonsregistret ägarbyte
rehabassistent uppsala
vitalograph spirometer manual
kreditkarte beantragen
översätt magisterexamen till engelska
vadstena antik och kuriosa öppettider
Guard Therapeutics
AGOURA HILLS, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, today announced that ArtiShield TM is now approved for manufacture and marketing by the Ministry of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy), license number UK.AY-401/2018, for the treatment Köp aktier i Aclaris Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Shares in Mateon Therapeutics Inc are currently priced at $0.303. At that level they are trading at 0.538% discount to the analyst consensus target price of 0.00. Analysts covering Mateon Therapeutics Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.07 for the next financial year.
Köp Mateon Therapeutics Inc Common Stock MATN aktier
Klicka här för att följa aktiekursen i realtid.
der ISIN US57667K1097 . Sie weist dabei eine hohe Streubesitzquote von 67% auf. Die Mateon Therapeutics Inc Aktie wird unter der ISIN US57667K1097 an den Börsen Berlin und Nasdaq OTC gehandelt. Mateon Therapeutics Inc ist ein Unternehmen aus den USA. Im gleichen Bereich tätige Unternehmen sind z Mateon Therapeutics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de.